Cambridge Investment Research Advisors’s Kenvue KVUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
134,745
-5,920
-4% -$104K 0.01% 1482
2026
Q1
$2.42M Sell
140,665
-12,002
-8% -$214K 0.01% 1459
2025
Q4
$2.63M Buy
152,667
+14,350
+10% +$235K 0.01% 1318
2025
Q3
$2.25M Buy
138,317
+22,464
+19% +$459K 0.01% 1415
2025
Q2
$2.42M Buy
115,853
+9,713
+9% +$221K 0.01% 1284
2025
Q1
$2.54M Buy
106,140
+4,034
+4% +$89.3K 0.01% 1196
2024
Q4
$2.18M Buy
102,106
+14,720
+17% +$334K 0.01% 1302
2024
Q3
$2.02M Buy
87,386
+6,522
+8% +$135K 0.01% 1338
2024
Q2
$1.47M Buy
80,864
+2,373
+3% +$46K 0.01% 1499
2024
Q1
$1.68M Buy
78,491
+4,123
+6% +$83.7K 0.01% 1380
2023
Q4
$1.6M Sell
74,368
-15,730
-17% -$315K 0.01% 1349
2023
Q3
$1.81M Buy
+90,098
New +$2.09M 0.01% 1199

Other funds holding KVUE

Cambridge Investment Research Advisors's KVUE Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Kenvue (KVUE) stake by 4.2% in Q2 2026, selling an estimated $104K and leaving 134,745 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #1482.

Cambridge Investment Research Advisors first reported a position in KVUE in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.63M in Q4 2025. 1,004 funds tracked by Wall St. Rank hold KVUE as of Q2 2026.

  • Cambridge Investment Research Advisors held 134,745 shares of Kenvue worth $2.58M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 5,920 Kenvue shares in Q2 2026, an estimated $104K.
  • Kenvue made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1482 holding.
  • Cambridge Investment Research Advisors first reported a position in Kenvue in Q3 2023 and has held it in 12 quarters since.
  • Cambridge Investment Research Advisors's Kenvue position peaked at $2.63M in Q4 2025.
  • 1,004 funds tracked by Wall St. Rank held Kenvue as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.